Stocktoria
TENAX THERAPEUTICS, INC. TENX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1993-10-28
TENAX THERAPEUTICS, INC. statistics & valuation
Market cap$356.5M
P / B3.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -50.5% | -18.2% | -66.0% | 324.5% | -541.9% |
| Return on equity | -54.2% | -19.1% | -95.2% | 740.0% | -765.1% |
| Current ratio | 14.56 | 20.60 | 3.26 | 1.74 | 3.64 |
Source: SEC EDGAR filings · CIK 0000034956 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.